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Abstract
Background: Deep dermal burns require tangential excision of non-viable tissue and skin grafting to improve
wound healing and burn-scar quality. Tangential excision is conventionally performed with a knife, but during the
last decade hydrosurgery has become popular as a new tool for tangential excision. Hydrosurgery is generally
thought to be a more precise and controlled manner of burn debridement leading to preservation of viable tissue
and, therefore, better scar quality. Although scar quality is considered to be one of the most important outcomes in
burn surgery today, no randomized controlled study has compared the effect of these two common treatment
modalities with scar quality as a primary outcome. The aim of this study is, therefore, to compare long-term scar
quality after hydrosurgical versus conventional tangential excision in deep dermal burns.
Methods/design: A multicenter, randomized, intra-patient, controlled trial will be conducted in the Dutch burn
centers of Rotterdam, Beverwijk, and Groningen. All patients with deep dermal burns that require excision and
grafting are eligible. Exclusion criteria are: a burn wound < 50 cm2, total body surface area (TBSA) burned > 30%,
full-thickness burns, chemical or electrical burns, infected wounds (clinical symptoms in combination with positive
wound swabs), insufficient knowledge of the Dutch or English language, patients that are unlikely to comply with
requirements of the study protocol and follow-up, and patients who are (temporarily) incompetent because of
sedation and/or intubation. A total of 137 patients will be included. Comparable wound areas A and B will be
appointed, randomized and either excised conventionally with a knife or with the hydrosurgery system. The primary
outcome is scar quality measured by the observer score of the Patient and Observer Scar Assessment Scale
(POSAS); a subjective scar-assessment instrument, consisting of two separate six-item scales (observer and patient)
that are both scored on a 10-point rating scale.
Discussion: This study will contribute to the optimal surgical treatment of patients with deep dermal burn wounds.
Trial registration: Dutch Trial Register, NTR6232. Registered on 23 January 2017.
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Background
Surgical debridement is an important step in the treat-
ment of patients with deep dermal burns. The purpose
is to remove necrotic and infectious materials and to
prepare tissue for skin grafting and definitive wound
closure [1]. Conventional surgical debridement of acute
burn wounds consists of sharp tangential excision of
non-viable tissue with hand-held knives such as the
Goulian or Weck knife [2]. Adequate debridement with
these knives is determined by the presence of punctuate
bleeding and a viable dermis. This procedure is not only
associated with substantial blood loss, but also with the
unnecessary removal of viable dermis [2, 3]. Loss of
dermis has been considered one of the main factors de-
termining the quality of the scar and the degree of con-
traction of the healing wound [4–6]. Therefore, methods
which maximally preserve dermis are essential. During
the last decade, hydrosurgery has become popular in
burn surgery as a new option for excision of non-viable
tissue prior to skin grafting [7–9]. The Versajet™ hydro-
surgery system (Smith and Nephew, St. Petersburg, FL,
USA) was developed in 1997 for the purpose of debrid-
ing various types of wounds, including burn wounds,
and is superseded by the Versajet II™ (Smith and
Nephew) in 2011 [8]. The Versajet II™ system works by
producing a high-pressure jet of water across an aper-
ture in an angled handpiece. The Venturi effect creates a
vacuum that removes surface debris which is sucked into
the machine together with the irrigation fluid. The cutting
and aspiration effects can be controlled by adjusting con-
sole power settings, handpiece orientation, and handpiece
pressure. The vacuum that is created by the speed of the jet
aims to lift only non-viable tissue and thus maximal dermal
preservation could be achieved. For this reason, hydrosurgi-
cal debridement of burns might lead to a better scar out-
come compared to conventional sharp debridement.
Although burn specialists widely use hydosurgery as
an alternative for conventional tangential debridement
[6, 7] only a limited number of studies are available on
the effects of hydrosurgery in burn patients [10–12]. A
guideline from the National Institute for Health and Care
Excellence (NICE) recently reported that the Versajet™ is
an efficient and safe wound debridement tool in both
adults and children with acute and chronic wounds [8].
Up to now, two randomized controlled trials comparing
hydrosurgical and conventional debridement in patients
with burns have been published [13, 14].
Gravante et al. stated that adequate debridement of
the wound bed was possible in all patients treated with
the Versajet™ system [13]. The authors suggested that
hydrosurgical excision was more precise in obtaining the
correct dermal plane, but did not confirm this with ob-
jective measurements. Hyland et al. studied children
under the age of 16 years and histologically confirmed
that significantly more viable dermis was preserved in
the group of patients treated with hydrosurgery com-
pared to the conventionally treated group of patients
[14]. However, they did not observe significant differ-
ences in scar quality measured with the Vancouver Scar
Scale (VSS) at 3 and 6 months post burn. Furthermore,
they did not use any objective scar measurement tools
and the study was limited by a relatively short follow-up
period as scars mature over a period of at least 1 year
[15, 16]. Also, the VSS was formally not designed to in-
dicate burn scar severity, has a moderate reliability and
does not include the opinion of the patient [17]. Hence,
it remains unclear whether hydrosurgery for the routine
debridement of deep dermal burns prior to skin grafting
leads to increased dermal preservation and better scar
quality outcomes.
The aim of this study, therefore, is to assess the effect-
iveness of hydrosurgical compared to conventional de-
bridement in deep dermal burns. Long-term scar quality
after hydrosurgical and conventional debridement of
deep dermal burns in relation to histologically measured
dermal preservation will be analyzed.
Methods/design
Protocol and registration
The study was approved by the Medical Ethics Committee
(NL58875.101.16) and by the Institutional Review Boards
of each participating burn center. The methods applied
were specified in advance, documented in a protocol,
and registered (http://www.trialregister.nl, NTR6232).
The protocol has been designed in accordance with the
SPIRIT (Standard Protocol Items: Recommendations for
Interventional Trials) guidelines for interventional trials
[18]. The SPIRIT Checklist and Figure are given in
Additional file 1 and Fig. 1, respectively.
Study design
A multicenter, randomized controlled trial with an intra-
patient comparison of hydrosurgical and conventional
debridement will be conducted in the three Dutch burn
centers: Rotterdam, Beverwijk, and Groningen. As the
healing process of burn wounds and scar formation dif-
fers between patients we chose an intra-patient design
to provide representative outcomes and to limit inter-
patient bias.
Participants
Patients of all ages with deep dermal burns and an indica-
tion for tangential excision and skin grafting are eligible for
this trial, either hospitalized or under treatment in the
outpatient clinic of one of the participating burns centers.
Exclusion criteria are as follows: a burn wound < 50 cm2,
total body surface area (TBSA) burned > 30%, full-thickness
burns, chemical or electrical burns, infected wounds (clinical
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symptoms in combination with positive wound swabs),
patients with insufficient knowledge of the Dutch or English
language, patients who are unlikely to comply with require-
ment of the study protocol and follow-up, and patients who
are (temporarily) incompetent because of sedation and/or
intubation.
Patients are included after receiving a full, understand-
able and neutral explanation of the study by a member
of the research team and after having given written in-
formed consent.
Interventions
Conventional tangential excision
Tangential excision with guarded knives relies on the
stepwise excision of a layer of tissue using a flat blade.
The addition of a guard prevents the removal of exces-
sive amounts of tissue, and most of these knives allow
adjustment of the width of the gap between the blade
and the guard. However, if the gap is too narrow the in-
strument will glide off the burn without any debride-
ment taking place [2].
Hydrosurgical tangential excision
The Versajet™ II hydrosurgery system (Smith and Nephew.
St. Petersburg, FL, USA) was CE marked in 2011 and was
launched in 2012 [8]. It uses a high-pressure jet of sterile
saline to debride wounds. It is attached to a console,
which is then operated by a foot pedal. The saline is forced
out of a narrow nozzle and functions like a knife which al-
lows debridement and aspiration of debris to occur simul-
taneously. Pressure can be adjusted (power setting 1–10)
to facilitate the desired depth of debridement. As a result,
the correct level might be reached more accurately,
preserving as much dermis as possible. Hydrosurgery is
preferentially suited to debride softer necrotic tissues, and
cannot be used to debride full-thickness burns as it does
not cut through hard eschar. Versajet™ is reported to be
used routinely in multiple centers around the world these
days [8]. Nevertheless, a clear algorithm for its use is
lacking, and burn specialists may choose individually
whether hydrosurgery can be applied or not [9].
Surgical procedure
Prior to surgery, the surgeon divides the study area into
two adjacent parts of equal size and burn depth (part A
and part B). These parts are randomly allocated to either
conventional or hydrosurgical (Versajet™) tangential de-
bridement. Two 3-mm punch biopsies of both intervention
areas will be collected before and after debridement, ac-
cording to a standardized method (Fig. 2), to determine the
amount of viable dermis before and after excision. Type of
Fig. 1 Schedule of enrollments, interventions and assessments
Fig. 2 Location of punch biopsies. a Biopsy part A, before debridement.
b Biopsy part B, before debridement. c Biopsy part A, after debridement.
d Biopsy part B, after debridement
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mesh graft and expansion will also be standardized per pa-
tient to ensure an equal mesh cover of the two intervention
areas. Before and after surgery, standard wound care is
given. After discharge, patients will be treated in an out-
patient setting according to the local protocol.
Study outcomes
Primary outcome measure
Our primary outcome measure is scar quality assessed
by the items of the observer scale of the Patient and
Observer Scar Assessment Scale (POSAS) at 12 months
post surgery. The POSAS is recognized as a highly reliable
scar rating scale, and consists of two numeric scales: the
Patient Scar Assessment Scale (patient scale) and the
Observer Scar Assessment Scale (observer scale) [19, 20].
The observer scale contains the items vascularization, pli-
ability, pigmentation, thickness, and relief. All items will
be measured for part A and part B of the study wound on
a 10-point rating scale by two experienced, trained, and
independent observers to improve the reliability of the as-
sessment. The average of the observers’ scores will range
from 1, which corresponds to the situation of normal skin,
to 10, indicating the “worst” imaginable scar.
Secondary outcome measures
Subjective scar assessment Scar quality of part A and
part B of the study area will be measured at 3, 6, and
12 months post surgery using the POSAS. Although the
total score of the observer scale at 12 months is our pri-
mary outcome, the items of the patient scale of the
POSAS will also be measured and analyzed separately.
The patient scale of the POSAS contains the items color,
pliability, thickness, relief, itching, and pain. These items
will be scored on a 10-point rating scale and added to
form the total patient score. In addition, patients and ob-
servers will score their overall opinion on the scar (1–10,
numeric scale), and total scores of the patient and ob-
servers will be added to form a total score.
Scar elasticity Scar elasticity will be measured with the
Cutometer® (Courage-Khazaka electronic GmbH Cologne,
Germany). The Cutometer® is a validated instrument to
measures the viscoelasticity of the skin by analyzing its
maximal extension (Uf in millimeters) in response to
negative pressure [21].
Scar color and pigmentation Scar color and pigmenta-
tion will be measured with the Dermaspectrometer®
(Cortex Technology ApS Hadsund, Denmark), which is
a reliable narrowband spectrometer that computes an
erythema and melanin index [19].
Measurements with the Cutometer® and Dermaspect-
rometer® are performed at 3 and 12 months post burn
on both parts (A and B) of the study area, and adjacent
normal skin. For objective data collection, measurements
will be performed following a fixed protocol.
Dermal preservation During surgery, two punch biop-
sies will be taken out of both parts (A and B) of the
study area, pre and post debridement, using a 3-mm
punch. The biopsies will be fixed in kryofix and proc-
essed into 3–5-μm histological slides. Sections will then
be stained with hematoxylin and eosin (H&E) or picro-
sirius red. To determine the amount of dermal preserva-
tion and hence precision of debridement, the amount of
viable tissue on pre- and post-debridement specimens
will be recorded using light microscopy.
Baseline characteristics Data registration will start on
the day of randomization. Data regarding patients’ base-
line characteristics will be obtained from patients’ med-
ical records:
 Demographics: age, gender
 Burn characteristics: percent TBSA burned, affected
anatomical site(s), wound etiology, time to surgery,
and burn depth of the study area. If possible, burn
depth will accurately be determined on days 2–5 post
burn by clinical evaluation and laser Doppler imaging
(LDI) scan using the moorLDI2-Burn Imager™ (Moor
Instruments, Axminster, UK) or similar [22]
 Clinical characteristics: skin type according to
the Fitzpatrick skin type scale; wound healing time
(measured in days till 95% re-epithelization);
comorbidity; Weck knife, Versajet™, and dermatome
settings; expansion of skin graft; adverse events
(graft loss, wound infection); and need for
reconstructive surgery.
Sample size
Power calculation is based on the results obtained by an
unpublished retrospective study on scar quality after
hydrosurgery versus guarded knife excision in the Martini
Hospital in Groningen [9]. The primary outcome measure
was scar quality assessed from photographs, and expressed
in the total score of the observer part of the POSAS. Be-
cause scar quality was assessed from photographs, pliability
was not taken into account [23]. Therefore, scar assess-
ment contained the four items vascularization, pigmenta-
tion, thickness, and relief.
The lowest sum score, reflecting normal skin, was 4
and the highest score, reflecting the worst imaginable
scar, was 40. In this study, the observer score of the
POSAS questionnaire 12 months post surgery was 14.7
in the hydrosurgery groups versus 16.7, with a pooled
standard deviation (SD) of 6.53. This results in an effect
size of 0.3. Because of the within-subject design, a cor-
rection for correlated samples was included, assuming a
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correlation of 0.4 between POSAS observer score within
one patient. Given a power of 0.8 and a level of signifi-
cance of 0.05 a number of 105 patients is needed. Assum-
ing a 30% dropout, 137 patients need to be recruited.
Randomization
Randomization will occur in the operating theater after
the wound is divided into two comparable study areas,
defined as part A and part B. These areas are randomly
assigned to receive either hydrosurgical or conventional
debridement. Allocation of the treatment will be stratified
per institute in blocks using the online randomization
program CASTOR, https://data.castoredc.com. The out-
come will be displayed on the website, only visible for
the person who performed the randomization and the
principal investigator. After randomization, the central
trial coordinator will receive instructions with the in-
clusion number.
Blinding
Patients are blinded as they are sedated during surgery
and will not be aware which treatment they received on
which part of the wound. Blinding surgical treatment is
not possible, as the burn surgeon knows which part of
the wound received which surgical treatment. Outcome
assessment is blinded as the member of the research
team who performs the follow-up measurements is un-
aware of the technique used for debridement of part A
or part B. In case of randomization-related difficulties,
the central trial coordinator can be contacted.
Statistical analysis
Data analysis will be performed using SPSS PASW
Statistics 23.0 (IBM, New York City, NY, USA).
Primary outcome
Differences in scar quality 12 months post surgery, assessed
as the total score of the observer scale of the POSAS, will
be analyzed using the paired Student t test (in case of
normal distribution) or the Wilcoxon signed-rank test
(non-normal distribution).
Secondary outcomes
Differences in 12-month outcomes of the patient scar
assessment, the observer scar assessment, scar elasticity
(measured by the Cutometer®), scar color (measured by
the DermaSpectrometer®) and differences in viable dermis
after excision (measured by histopathology) will be analyzed
using the Wilcoxon signed-rank test in case of non-normal
distribution, or the paired Student t test in case of normal
distribution. Because of repeated measurements within
patients and loss to follow-up, overall differences of scar
quality measurements will be analyzed using generalized
estimating equations, with unstructured working correl-
ation matrix structure.
Discussion
In this paper, we have described the design of our
study into long-term scar quality after hydrosurgical
and conventional tangential excision of deep dermal
burns. This will be the first study that assesses dif-
ferences in scar quality between both treatment
modalities at 12 months post surgery in both adults
and children with subjective and objective measure-
ment tools.
Subjective scar quality will be assessed using the POSAS.
The POSAS is unique as it takes the opinion of the patients
into account which is mandatory for a clinically relevant
scar evaluation [24].
Scar quality will not only be measured subjectively,
but also with objective measurement tools concerning
scar pigmentation, vascularity, and pliability. Aside from
these evaluations, we want to support our results via
quantitative analysis of the histological specimens. For a
reliable follow-up, documentation of which area of the
wound is part A, and which area is part B needs to be
specific to allow accurate assessment of the correct
areas, as it is possible that there might be no differences
visible at follow-up.
In this study, an accurate diagnosis of wound depth
is essential to determine the indication for surgery.
Therefore, all three burn centers are in possession of
an LDI scan to assess burn wound depth, which has
an accuracy of 95% in combination with a clinical
evaluation of the wound [22, 25, 26]. Moreover, it
can be used to make sure that part A and part B of
the study area are of equal burn depth. To enhance
the applicability and generalizability of this trial, we
chose a multicenter trial design and will recruit pa-
tients treated in one of the three national Dutch burn
centers. To increase generalizability, and because of
the intra-patient design, we are forbearing regarding
local clinical care; for example, timing of surgery and
type of wound dressings. This study will contribute
to the optimal surgical treatment of patients with
deep dermal burn wounds and the results should be
of high international value, as hydrosurgery is used
worldwide.
Trial status
This manuscript is a restructured and edited version of
the REC approved protocol (version 3.2, 6 February 2017)
to comply with the SPIRIT guidelines. Recruitment
opened on January 10, 2017, and is expected to be com-
pleted in January 2019. As of 16 April 2018, 56 patients
had been recruited.
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